About this trial

The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.

Eligibility criteria

Qualifiers

Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months.

Diagnosis of unexplained (primary or secondary) infertility

Hunault <30% (or >30%, after an expectant management period of at least 6 additional months).

Females aged >18 years with regular menstrual cycle.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Progesterone Vaginal Product
  • Placebo

Treatment groups

1,008 Participants
are divided into 2 treatment groups

Locations

1
UMC Utrecht Utrecht Netherlands

Sponsors and collaborators

UMC Utrecht

Lead sponsor